Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
4.440
+0.110 (2.54%)
At close: Apr 14, 2026, 4:00 PM EDT
4.440
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:01 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $287.57 million as of April 14, 2026. Its market cap has decreased by -63.05% in one year.
Market Cap
287.57M
Enterprise Value
382.88M
1-Year Change
-63.05%
Ranking
Category
Stock Price
$4.44
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $287.57M, an increase of 6.00%. That is a compound annual growth rate of 0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 281.70M | -34.66% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kamada | 483.41M |
| Emergent BioSolutions | 425.55M |
| Canopy Growth | 413.53M |
| Akebia Therapeutics | 393.78M |
| SIGA Technologies | 319.53M |
| Organogenesis Holdings | 306.16M |
| Anika Therapeutics | 199.54M |
| Aurora Cannabis | 197.47M |